By the My Sarkari Result Exam editorial team · Updated July 28, 2026
Is Wegovy covered by insurance? The honest answer in 2026 is: sometimes — and it depends far more on your specific plan than on the drug itself. Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management and for reducing cardiovascular risk in certain adults, and that second approval has pushed more insurers to cover it. But many employer plans still exclude weight-loss medications entirely, Medicare’s rules are narrow, and nearly every plan that does cover Wegovy requires prior authorization. This guide explains exactly who tends to be covered, what the drug costs with and without insurance, and the step-by-step process — including appeals — that gets real patients approved.
Is Wegovy Covered by Insurance? The Short Answer by Plan Type
Coverage breaks down very differently across the four main ways Americans get insurance:
- Employer plans: the biggest wildcard. Large employers increasingly add GLP-1 coverage, but a substantial share still carve out all “weight-loss drugs” regardless of medical need. Your Summary of Benefits or formulary is the only reliable answer.
- ACA marketplace plans: most exclude weight-loss medication, since it isn’t an essential health benefit. A minority of states and insurers cover it with strict criteria.
- Medicare: Part D plans have historically been barred from covering drugs used for weight loss. Because Wegovy also carries a cardiovascular-risk indication, many Part D plans now cover it for that specific use — established heart disease plus overweight or obesity — but not for weight loss alone. Check your plan’s formulary at Medicare.gov.
- Medicaid: varies state by state. Some state Medicaid programs cover Wegovy with prior authorization; others don’t cover anti-obesity medication at all. Your state Medicaid formulary is the source of truth.
Across all of these, the pattern is the same: coverage exists, but it’s conditional — tied to your BMI, your diagnoses, prior treatment history, and paperwork your prescriber files.
What Wegovy Costs With and Without Insurance in 2026
Wegovy’s list price has hovered around $1,350 per month, though the manufacturer has offered direct-purchase pricing around $499/month for self-paying patients through its own pharmacy channel — figures that change, so verify current pricing before budgeting. What you actually pay depends on your coverage tier and deductible.
| Situation | Typical monthly cost in 2026 | Notes |
|---|---|---|
| Commercial insurance, covered + manufacturer savings card | $0–$25 | Savings card caps copays for eligible commercially insured patients |
| Commercial insurance, covered, no card | $25–$150 | Depends on formulary tier and whether deductible is met |
| Medicare Part D (cardiovascular indication) | $50–$200+ | Varies by plan phase; $2,000 annual out-of-pocket cap helps |
| Medicaid (states that cover it) | $0–$10 | Nominal copays where covered |
| No coverage — manufacturer self-pay program | ~$499 | Direct-to-patient pricing; subject to change |
| No coverage — retail list price | ~$1,350 | Cash price at a pharmacy without any program |
Prices are estimates compiled from manufacturer and plan disclosures as of mid-2026 and change frequently; confirm with your pharmacy and plan.
Who Qualifies: The Criteria Insurers Actually Use
When a plan does cover Wegovy, its prior-authorization criteria usually mirror the FDA label. Expect the insurer to require most or all of the following:
- BMI of 30 or higher, or BMI of 27+ with at least one weight-related condition such as high blood pressure, type 2 diabetes, obstructive sleep apnea, or high cholesterol.
- Documented lifestyle intervention — typically 3–6 months of a reduced-calorie diet and increased activity, sometimes through a structured program.
- Prescriber documentation of baseline weight, comorbidities, and treatment goals.
- Step therapy in some plans: trying a lower-cost medication first.
- Reauthorization every 6–12 months, often requiring proof of roughly 5% weight loss to continue coverage.
For Medicare’s cardiovascular pathway, the criteria are different: documented established cardiovascular disease (such as a prior heart attack or stroke) plus a qualifying BMI. Weight loss alone does not qualify under Part D rules.
How to Get Wegovy Covered: A Step-by-Step Playbook
Step 1: Read your formulary before your appointment
Log in to your plan portal and search the drug list for “Wegovy” and “semaglutide.” Note the tier, whether prior authorization (PA) or step therapy is flagged, and any quantity limits. If it’s excluded outright, jump to the alternatives section below.
Step 2: Have your prescriber file a complete prior authorization
Most denials happen because the PA is missing data — no documented BMI history, no comorbidity codes, no record of lifestyle attempts. Ask your clinician (in-person or via a telehealth weight-management service) to include all of it up front.
Step 3: If denied, appeal — and expect to win more than you’d think
Plans must give a denial reason in writing. First-level appeals with added documentation (a letter of medical necessity, weight and comorbidity history, cardiology notes for the CV indication) frequently succeed. You also have the right to an external review by an independent reviewer if internal appeals fail — see HealthCare.gov’s appeals guide.
Step 4: Stack the savings card if you’re commercially insured
The manufacturer’s savings program can reduce covered patients’ copays to as little as $0–$25/month. It cannot be used with Medicare or Medicaid — federal rules prohibit copay cards in government programs.
Step 5: Price the self-pay route as a fallback
If your plan excludes the drug, compare the manufacturer’s direct self-pay pricing, legitimate pharmacy discount programs, and whether a covered alternative exists. Avoid unregulated “compounded semaglutide” sellers; the FDA has warned about safety and dosing risks with unapproved versions — see FDA.gov.
If Wegovy Isn’t Covered: Realistic Alternatives
- Zepbound (tirzepatide): a different GLP-1-class drug for weight management; some formularies prefer it over Wegovy, so a denied Wegovy PA sometimes converts to an approved Zepbound one.
- Ozempic or other semaglutide products for diabetes: covered far more often — but only for patients who actually have type 2 diabetes. Insurers audit this; off-label routing can trigger clawbacks.
- Older generics: phentermine, bupropion-naltrexone, and orlistat cost a fraction of GLP-1s and are covered more broadly, with more modest average results.
- Bariatric surgery: paradoxically covered by many plans that exclude weight-loss drugs; worth discussing for higher BMIs.
- Employer advocacy: coverage is a plan-design choice. HR benefits teams do add GLP-1 riders when employees ask; open-enrollment season is the time to push.
FAQ: Is Wegovy Covered by Insurance?
Is Wegovy covered by insurance for weight loss alone?
On many commercial plans, yes — with prior authorization and BMI criteria. On Medicare Part D, no; coverage requires the cardiovascular-risk indication. Medicaid depends on your state.
Does Medicare cover Wegovy in 2026?
Many Part D plans cover it only for adults with established cardiovascular disease and overweight or obesity, per its FDA-approved heart indication. Coverage for weight loss by itself remains excluded under current law.
How much is Wegovy with insurance?
Commercially insured patients with coverage commonly pay $0–$150/month depending on tier, deductible, and whether they use the manufacturer savings card.
Why did my insurance deny Wegovy?
The most common reasons: the plan excludes weight-loss drugs entirely, the prior authorization lacked BMI/comorbidity documentation, step therapy wasn’t completed, or reauthorization criteria (like 5% weight loss) weren’t documented. Denials based on missing paperwork are the most appealable.
Can I use the Wegovy savings card with Medicaid or Medicare?
No. Federal anti-kickback rules bar manufacturer copay cards in government programs. The card works only with commercial insurance.
Is compounded semaglutide a safe cheap alternative?
The FDA has warned against unapproved compounded semaglutide products, citing dosing errors and unverified ingredients. If cost is the barrier, the manufacturer’s self-pay program or a covered alternative is a safer path — discuss options with a licensed clinician.
Medical Disclaimer: This article is for general educational purposes only and is not medical, financial, or insurance advice. Wegovy is a prescription medication with real risks and side effects; whether it is appropriate for you is a decision for you and a licensed healthcare provider. Coverage rules, prices, and program criteria change frequently — verify current details with your insurer, your pharmacy, Medicare.gov, or your state Medicaid program.